List of All Articles with Tag 'nda'

Eva Mendes has revealed that she doesn’t let her and Ryan Gosling’s daughters use the internet. The actor, 49, took to Instagram on 3 August to share one of the rules that she has for her and Gosling’s daughters - Esmeralda, eight, and Amada, seven. Mendes shared a video of herself shaking her head no and wagging her finger, as she pointed out that’s how she responds to her children when they ask to use the internet. “When my kids ask me if they’re old enough to go on the internet, social media or anything requiring wifi,” she wrote in the caption. When a fan in the comments asked when she will allow her children use the internet, Mendes candidly confessed that she’s still figuring that out. She also specified that she’s been doing research on how social media can impact children as they continue to get older. “I honestly don’t know. I have to see where it goes,” the Hitch star responded. “For now, I’m observing them and keeping up with research about how social media can impact a child’s brain.” She responded to another fan who praised her parenting decision, with Mendes noting that while she’s “just sharing what [she] feels now”, she thinks it’ll be harder to keep her children away from the internet as they get older. Mendes clarified that her children are still given screentime, adding: “I let my kids use the iPad to make movies and watch films I’ve downloaded, but I don’t have internet access on the iPad.” The actress was also hit with some criticism for her parenting rule, with one Instagram user writing: “We are in the internet century so eventually everyone will need or want to access the internet sorry.” While it appears the comment has since been deleted, Mendes responded to the remark by explaining why she doesn’t feel like the internet is a safe space for her children. “In my house, children do not have access to the internet,” she responded to the remark, as reported by E! News. “It’s too dangerous. Just like drinking or voting or getting a driver’s license (etc..) isn’t allowed for children, the internet falls under that category for me. Especially social media.” While Mendes and Gosling - who’ve been together since 2011 - are notoriously private about their family life, the couple have shared a few details about raising children together. During an interview with Byrdie in July 2022, Mendes explained that she and her partner want to make sure that their children feel confident in themselves throughout everything they do in life. “Hopefully Ryan and I are doing the work by just loving them, completely loving them, and doing most of that work for them so that they grow up feeling like they’re enough,” she said. “That’s the one thing that’s really important to me. Because once they feel like they’re enough, no matter what they do, no matter what they end up doing, that will feed into every area of your life. Especially into how attractive you feel, or any of that stuff.” In a cover story interview with GQ in June, Gosling also shared some candid thoughts about fatherhood. He revealed that prior to his relationship with Mendes, he didn’t think much about becoming a father. However, that all changed when Mendes told him she was pregnant. “Eva said she was pregnant,” he recalled. “I would never want to go back, you know? I’m glad I didn’t have control over my destiny in that way, because it was so much better than I ever had dreamed for myself.” Elsewhere in the interview, the Barbie star clarified previous comments he made about the moment Mendes learned she was pregnant. While he maintained that he “wasn’t thinking about kids” before they met, Gosling said: “After I met Eva, I realised that I just didn’t want to have kids without her.” Read More Eva Mendes shows off dress made out of sponges as she jokes it’ll be her Oscars outfit Ryan Gosling’s daughters hilariously prove ‘nobody plays with Ken’ Ryan Gosling’s subtle tribute to Eva Mendes at the Barbie premiere Eva Mendes reveals she doesn’t let her daughters use the internet What is Stiff Person Syndrome? Nearly half of US adults are interested in taking weight loss prescription drugs

Randall Park's directorial debut ‘Shortcomings’ was inspired by Noah Baumbach’s ‘Marriage Story’ and Greta Gerwig's previous works.

The endangered red panda population recently received a boost in the form of adorable twin babies.

There are reports of a surge in men wanting to know if they are the biological fathers of their children.

A new survey has found that nearly half of adults in the United States are interested in taking prescription drugs for weight loss, such as Ozempic or Wegovy. In a KFF health tracking poll published on 3 August, researchers reported that 45 per cent of adults said they’d be interested in taking a “safe and effective” prescription drug for weight loss. Meanwhile, seven in 10 adults said they’ve heard at least “a little” about a new class of drugs being used for weight loss, with about one in five saying they have heard “a lot” about these drugs. Ozempic is a type 2 diabetes medication known for its weight loss side effects. Similar semaglutide injections, such as Wegovy and Mounjaro, have been specifically approved for the treatment of obesity and weight loss. This class of drugs called GLP-1 agonists works by mimicking a hormone called glucagon-like peptide 1 (GLP-1), regulating blood sugar levels and slowing down the rate at which food leaves the stomach to create the feeling of fullness. Of the US adults surveyed, older groups were some of the most aware of prescription weight loss drugs, with 76 per cent being those who have been told by a doctor in the past five years that they are overweight or obese. Nearly 60 per cent of those surveyed said they were currently trying to lose weight as well. While there was an overall interest in taking a prescription weight loss drug, that interest significantly decreased when people were asked whether they would take the medication as a routine injection. Only 16 per cent of adults said they would still take Ozempic or Wegovy, even if it wasn’t covered by their health insurance and was not specifically approved by the US Food and Drug Administration for weight loss. In fact, most people believed that insurance companies should cover the cost of weight loss drugs for adults who are overweight or obese, with an overwhelming 80 per cent of adults. Additionally, a large majority of adults believed the substantial profits that pharmaceutical companies have made from increased demand for weight loss drugs is a major factor contributing to the cost of injections like Ozempic and Wegovy. According to Novo Nordisk, the pharmaceutical company behind these prescription drugs for diabetes and weight loss, the list price for Ozempic can cost $935.77 per month without health insurance. Although the majority of adults said they trust pharmaceutical companies like Novo Nordisk to provide “reliable information” about safety and side effects of GLP-1 agonists, only 22 per cent said they trust these companies to price their products fairly. The FDA has listed the most common side effects of taking Wegovy as nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, indigestion, dizziness, and digestive disorders. More serious complications can occur from use of Wegovy or Mounjaro, such as the “potential risk of thyroid C-cell tumours,” pancreatitis, gallbladder problems, acute kidney injury, increased heart rate, and suicidal behaviour or thinking. Taking Ozempic can also lead to possible thyroid tumours, including cancer, pancreatitis, changes in vision, and kidney and gallbladder problems. Recently, several patients reported suffering from severe gastroparesis, also known as stomach paralysis, after taking the prescription weight loss medications. In a report from CNN, two people claimed that their “stomachs are paralysed” after taking Ozempic. “I wish I never touched it. I wish I’d never heard of it in my life,” Joanie Knight, a 37-year-old from Louisiana, told CNN. “This medicine made my life hell. So much hell. It has cost me money. It cost me a lot of stress; it cost me days and nights and trips with my family. It’s cost me a lot, and it’s not worth it. The price is too high.” One woman was also diagnosed with cyclic vomiting syndrome, which causes her to throw up multiple times a day. “I’ve almost been off Ozempic for a year, but I’m still not back to my normal,” said Emily Wright, a 38-year-old teacher from Toronto. Shortly after the report, the FDA shared in a statement with The Independent that it has become aware of stomach paralysis occurring among patients taking the medications. “The FDA has received reports of gastroparesis with semaglutide and liraglutide, of which some documented the adverse event as not recovered after discontinuation of the respective product at the time of the report,” the agency said. However, officials clarified that they were unable to determine whether taking Ozempic or Wegovy was the cause of stomach paralysis, or if it was caused by a different issue. “Gastroparesis can be a complication of diabetes that is related to long-standing or poorly controlled disease, further complicating the ability to determine what role the drugs played in the reported events,” the FDA added. In response to reports of stomach paralysis, drug manufacturer Novo Nordisk noted that these medications have been used to treat type 2 diabetes “for more than 15 years”, and for the “treatment of obesity” for eight years. “Semaglutide has been extensively examined in robust clinical development programs, large real world evidence studies and has cumulatively over 9.5 million patient years of exposure,” a spokesperson for Novo Nordisk said in a statement to The Independent. “Gastrointestinal (GI) events are well-known side effects of the GLP-1 class. For semaglutide, the majority of GI side effects are mild to moderate in severity and of short duration. GLP-1’s are known to cause a delay in gastric emptying, as noted in the label of each of our GLP-1 RA medications. Symptoms of delayed gastric emptying, nausea and vomiting are listed as side effects.” Read More Obese people on weight-loss jabs ‘should be prepared to stay on them for life’ Ozempic users report stomach paralysis as weight loss drug side effect: ‘I wish I never touched it’ Sharon Osbourne says she was ‘nauseous’ for weeks after taking Ozempic to lose weight Sharon Osbourne reveals what Ozempic did to her when she was taking it Ozempic users report stomach paralysis as side effect: ‘I wish I never touched it’ Lorraine Candy: ‘Perimenopausal rage made me unravel’

By David Shepardson WASHINGTON (Reuters) -Hyundai Motor and Kia said on Thursday they are recalling more than 113,000 newer vehicles

Groundbreaking and Oscar-winning filmmakers Spike Lee and Pedro Almodóvar are the first honourees announced for this year’s TIFF Tribute Awards.

An overview of the media in Niger, including links to broadcasters and newspapers.

The recall is the latest in a series of fire-related recalls of Hyundai and Kia models in recent years.

A cannabis operation in Cardiff was discovered when a man who tried to steal drugs was murdered.

Electric vehicles can offer several benefits like quietness, smooth power delivery and lower operating costs. Now, Hyundai Motor Group is adding another amenity to that list: a bigger and better glove compartment.

Stimulating the brain using electrodes could help ease symptoms of attention deficit hyperactivity disorder (ADHD) in children, a study has found. Transcranial random noise stimulation (tRNS) works by sending a mild electrical current to the brain through two electrodes on the scalp. The study, led by researchers from the University of Surrey and the Hebrew University of Jerusalem – and published in the Translational Psychiatry journal, explored the use of tRNS alongside cognitive training as a treatment for ADHD. Roi Cohen Kadosh, head of the School of Psychology and professor of cognitive neuroscience at the University of Surrey, said: “I believe that the scientific community is duty-bound to investigate and develop evermore effective and longer-lasting treatments for ADHD.” The clinical trial included 23 newly diagnosed and unmedicated children between the ages of six and 12, who were recruited from groups referred to the ADHD clinic by doctors, teachers, psychologists or parents. Researchers at the computerised neurotherapy lab at the Hebrew University of Jerusalem administered tRNS during cognitive training each weekday over a two-week period. The parents of 55% of the group reported “significant clinical improvement” in ADHD symptoms to researchers, compared to 17% in a control group that was given placebo brain simulation. Prof Kadosh said the findings demonstrate the treatment “has the potential to transform the lives of children and their families”. Future studies, with larger and more varied samples, should help establish this as a viable therapy for ADHD, and help us understand the underlying mechanisms of the disorder Dr Mor Nahum ADHD is a neurodevelopmental disorder and symptoms include hyperactivity, an inability to focus and impulsiveness. According to the National Institute for Health and Care Excellence (Nice), it is present in about 5% of children globally. Researchers are now preparing to start a larger clinical trial using tRNS and cognitive training. “If successful, this approach will be approved as a medical device for ADHD by the United States Food and Drug Administration,” Prof Kadosh said. Dr Mor Nahum is co-lead of the study and head of the computerised neurotherapy lab at the Hebrew University of Jerusalem. She added: “This is an important first step in offering new therapeutic options for ADHD. “Future studies, with larger and more varied samples, should help establish this as a viable therapy for ADHD, and help us understand the underlying mechanisms of the disorder.” Read More Charity boss speaks out over ‘traumatic’ encounter with royal aide Ukraine war’s heaviest fight rages in east - follow live Black LGBTQ+ icons everyone should know Ashley James: ‘We have a totally warped idea of what a mum should be’ Host Maya Jama’s glamorous Love Island outfits cost over £10,000